Lv11
30 积分 2024-12-30 加入
Associations between gut microbiota and Parkinson disease: A bidirectional Mendelian randomization analysis
4小时前
已完结
The risk factors for probable REM sleep behavior disorder: A case-control study
4小时前
已完结
Tocilizumab treatment in neuromyelitis optica spectrum disorders: Updated meta-analysis of efficacy and safety
20天前
已完结
Hope for patients with neuromyelitis optica spectrum disorders — from mechanisms to trials
21天前
已完结
Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial
21天前
已完结
Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial
22天前
已完结
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
22天前
已完结
Advances in maintenance therapies for neuromyelitis optica spectrum disorders: a new era of targeted drugs
23天前
已完结
Neuromyelitis optica
1个月前
已完结
Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson’s disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway
3个月前
已完结
皖公网安备34019202002308
